Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
about
Effects of Oxidative Stress on Mesenchymal Stem Cell BiologyPatient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell TherapyProgress and prospect of mesenchymal stem cell-based therapy in atherosclerosisIncreased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis.The Effects of Endocrine Disruptors on Adipogenesis and Osteogenesis in Mesenchymal Stem Cells: A Review.A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis.Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell FunctionErratum to: Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression.Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy.Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF‑α and TGF‑β1/ERK1/2 signaling pathways.Challenges in vascular tissue engineering for diabetic patients.IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate.Human Gingiva-Derived Mesenchymal Stem Cells Modulate Monocytes/Macrophages and Alleviate Atherosclerosis.
P2860
Q26740408-D5BEF9A5-9587-4EA5-83DA-BD5BA8656884Q26773103-51AD897E-89DA-4DCC-AC44-2FD2335C5315Q28075184-EB3C5B26-E9EA-4903-8292-3C4C83E31ADAQ37046334-3B70ACF7-673B-46DC-B5B3-53EAA38FF0A8Q37570411-AF1B7963-9B42-42E1-AC16-9E297B6D94F3Q38962768-203387C8-0F99-4A48-AE5E-693EE3C7538DQ41620009-4D6F0F93-E2AA-4E35-81B2-D4812A6EE740Q42321431-3C8B182F-0AF4-40AF-AEB2-C878B22F1D18Q47138584-699175C0-5D2A-414E-AFC7-9D144DA40E42Q49333970-FB63C370-A5FF-45EC-AA52-527FAE5B69D2Q49361293-2611500C-1B4B-466E-91C8-D1E3C111A368Q49905713-1E447B05-7C19-4E3B-92BF-04CECC129226Q55275182-53E0D1E5-C5B0-48B3-9488-5873677957FC
P2860
Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Age, atherosclerosis and type ...... ll-mediated T-cell suppression
@ast
Age, atherosclerosis and type ...... ll-mediated T-cell suppression
@en
type
label
Age, atherosclerosis and type ...... ll-mediated T-cell suppression
@ast
Age, atherosclerosis and type ...... ll-mediated T-cell suppression
@en
prefLabel
Age, atherosclerosis and type ...... ll-mediated T-cell suppression
@ast
Age, atherosclerosis and type ...... ll-mediated T-cell suppression
@en
P2093
P2860
P1476
Age, atherosclerosis and type ...... ll-mediated T-cell suppression
@en
P2093
Dominique Shum-Tim
Inés Colmegna
José A Correa
Ozge Kizilay Mancini
Ursula Stochaj
P2860
P2888
P356
10.1186/S13287-015-0127-9
P577
2015-08-08T00:00:00Z
P5875
P6179
1035193689